Human Pancreas-Derived Organoids with Controlled Polarity: Detailed Protocols and Experimental Timeline

Aletta Kiss1,2,3, Attila Farkas4, Ferhan Ayaydin4

  • 1Department of Internal Medicine, University of Szeged, Szeged, Hungary.

Current Protocols
|November 26, 2024
PubMed
Summary

Patient-derived organoids (PDOs) offer advanced 3D models for studying pancreatic exocrine function and disease. This guide details protocols for polarity switching in pancreatic PDOs, promoting human cell use over rodent models.

Related Concept Videos